ATRC Stock Analysis: Buy, Sell, or Hold?
ATRC - AtriCure, Inc.
$36.93
-0.02 (-0.05%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 11, 2026
10d
Get Alerted When ATRC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ATRC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ATRC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ATRC is currently trading at $36.93, which is considered oversold relative to its 30-day fair value range of $37.84 to $41.07.
Technical Outlook: Technically, ATRC is in a uptrend. The price is currently testing key support at $36.26. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $52.78 (+42.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ATRC is in a uptrend. The price is currently testing key support at $36.26. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $52.78 (+42.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$37.84 -
$41.07
Company Quality Score
54/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
80.0%
Protect Your Profits
Holding ATRC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 42.8% below Wall St target ($52.78)
- CAUTION: Recommendation downgraded due to -5.5% 5-day decline
Fair Price Analysis
30-Day Fair Range
$37.84 -
$41.07
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$2.46
(6.7%)
Support & Resistance Levels
Support Level
$36.26
Resistance Level
$41.80
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-282.06
Wall Street Target
$52.78
(+42.8%)
Revenue Growth (YoY)
15.8%
Profit Margin
-5.5%
Last updated: January 31, 2026 3:25 AM ET
Data refreshes hourly during market hours. Next update: 4:25 AM
Data refreshes hourly during market hours. Next update: 4:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATRC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Justin J Noznesky
SELL
3000 shares
2025-09-12
Sven Wehrwein
SELL
5000 shares
2025-08-22
Sven Wehrwein
SELL
5000 shares
2025-08-19
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$92 | 63 BUY |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$608 | 58 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$191 | 58 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$292 | 57 HOLD |
|
ALGN
Align Technology Inc |
BUY
18 analysts |
$184 | 62 BUY |
Advanced ATRC Option Strategies
Professional options setups generated by AI based on today's ATRC price and gamma walls.
